Immatics (IMTX) Enterprise Value (2019 - 2025)
Immatics' (IMTX) quarterly Enterprise Value came in at -$419.3 million in Q4 2025, up 33.07% year-on-year from -$315.1 million in Q4 2024, and down 7.8% quarter-over-quarter from -$388.9 million in Q3 2025.
Immatics (IMTX) Enterprise Value (2019 - 2025) Analysis & Trends
Immatics has disclosed Enterprise Value across 7 years of filings, most recently posting -$419.3 million for Q4 2025.
- Enterprise Value for Q4 2025 came in at -$419.3 million, up 33.07% year-over-year; the trailing twelve-month figure through Dec 2025 was -$419.3 million (up 33.07% YoY), and the FY2025 annual result was -$406.9 million, up 35.04% from the prior year.
- Enterprise Value came in at -$419.3 million for Q4 2025 at Immatics, down from -$388.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$155.4 million in Q1 2022 to a low of -$717.4 million in Q1 2024.
- The 5-year median for Enterprise Value is -$393.6 million (2023), against an average of -$408.6 million.
- Across the five-year window, Enterprise Value plunged 152.78% in 2021 and soared 43.72% in 2022, its largest moves.
- Immatics' Enterprise Value stood at -$166.0 million in 2021, then sank by 122.6% to -$369.5 million in 2022, then declined by 24.0% to -$458.2 million in 2023, then tumbled by 36.69% to -$626.4 million in 2024, then soared by 33.07% to -$419.3 million in 2025.
- The last three Enterprise Value figures came in at -$419.3 million (Q4 2025), -$388.9 million (Q3 2025), and -$541.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -419.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -419.25 Mn |
| Sep 30, 2025 | -388.90 Mn |
| Jun 30, 2025 | -541.29 Mn |
| Mar 31, 2025 | -571.97 Mn |
| Dec 31, 2024 | -626.38 Mn |
| Sep 30, 2024 | -570.85 Mn |
| Jun 30, 2024 | -636.91 Mn |
| Mar 31, 2024 | -717.36 Mn |
| Dec 31, 2023 | -458.24 Mn |
| Sep 30, 2023 | -469.28 Mn |
| Jun 30, 2023 | -398.26 Mn |
| Mar 31, 2023 | -386.85 Mn |
| Dec 31, 2022 | -369.54 Mn |
| Sep 30, 2022 | -266.47 Mn |
| Jun 30, 2022 | -205.14 Mn |
| Mar 31, 2022 | -155.36 Mn |
| Dec 31, 2021 | -166.01 Mn |
| Sep 30, 2021 | -258.79 Mn |
| Jun 30, 2021 | -289.32 Mn |
| Mar 31, 2021 | -276.05 Mn |